Applied Materials Other Income (Expense) increased by 36.2% to $771.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 248.9%, from $221.00M to $771.00M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 119.7% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $27.00M | $24.00M | $49.00M | $6.00M | $28.00M | -$7.00M | $12.00M | $50.00M | -$73.00M | $64.00M | $259.00M | $395.00M | $141.00M | $81.00M | $8.00M | $221.00M | $396.00M | $626.00M | $566.00M | $771.00M |
| QoQ Change | — | -11.1% | +104.2% | -87.8% | +366.7% | -125.0% | +271.4% | +316.7% | -246.0% | +187.7% | +304.7% | +52.5% | -64.3% | -42.6% | -90.1% | >999% | +79.2% | +58.1% | -9.6% | +36.2% |
| YoY Change | — | — | — | — | +3.7% | -129.2% | -75.5% | +733.3% | -360.7% | >999% | >999% | +690.0% | +293.2% | +26.6% | -98.0% | +56.7% | +388.9% | — | >999% | +248.9% |